
Epigenetics in Health and Disease
- 1st Edition, Volume 197 - April 3, 2023
- Editors: Vijai Singh, Indra Mani
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 6 6 9 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 6 7 0 - 7
Epigenetics in Health and Disease, Volume 197 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteEpigenetics in Health and Disease, Volume 197 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters on An Introduction to epigenetics in health and disease, State-of-the-art techniques for epigenetics study, Computational biology in epigenetics, Artificial intelligence and machine learning in epigenetics, CRISPR-Cas systems in epigenetics modification for health, Mechanisms of DNA methylation and histone modifications, Non-coding RNA in epigenetics, Role of DNA Methylation in cardiovascular diseases, Role of epigenetics in renal diseases, and much more.
Additional chapters update on Histone modifications in fat metabolism and obesity, Role of DNA methylation in diabetes and obesity, Epigenetic regulons in Alzheimer’s disease, Epigenetics in heredity disease, Epigenetics of aging, Epigenetics in cancer development, diagnosis and therapy, Microbiota and epigenetics: health impact, Epigenetics in Fetal Alcohol Spectrum disorder, and much more.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the Progress in Molecular Biology and Translational Science series
- Includes the latest information on Epigenetics in Health and Disease
Academic, government and industrial sectors
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One: Insight into epigenetics and human diseases
- Abstract
- 1: Introduction
- 2: Epigenetic mechanisms
- 3: Epigenetics and human diseases
- 4: Conclusion and future perspectives
- Conflict of interest
- References
- Chapter Two: State-of-the-art techniques to study epigenetics
- Abstract
- 1: Introduction
- 2: Histone modification analysis
- 3: DNA methylation profile analytic techniques
- 4: Conclusion and future perspectives
- Conflict of interests
- References
- Chapter Three: Mechanisms of DNA methylation and histone modifications
- Abstract
- 1: Introduction
- 2: DNA methylation sites
- 3: DNA demethylation and hydroxymethylation
- 4: DNA methylation and diseases
- 5: Importance of DNA methylation
- 6: Modification in histone
- 7: Histone modifications and diseases
- 8: Conclusion
- References
- Chapter Four: Epigenetics, genomics imprinting and non-coding RNAs
- Abstract
- 1: Introduction
- 2: Genomic imprinting and epigenetic alterations
- 3: Immunity and epigenetic changes between generations
- 4: Non-coding RNAs
- 5: Conclusions and the way forward
- Competing interests
- References
- Chapter Five: Epigenetics in cardiovascular health and disease
- Abstract
- 1: Introduction
- 2: Methodologies in the study of cardiovascular epigenetics
- 3: The landscape of epigenetic research in cardiovascular disease
- 4: Conclusion
- References
- Chapter Six: Histone modifications in fat metabolism and obesity
- Abstract
- 1: Introduction
- 2: Histone modifications in fat metabolism
- 3: Histone modifications in obesity
- 4: Conclusion and future direction
- Acknowledgment
- References
- Chapter Seven: Role of DNA methylation in diabetes and obesity
- Abstract
- 1: Introduction
- 2: DNA methylation and diabetes
- 3: DNA methylation and obesity
- 4: Conclusion and future direction
- References
- Chapter Eight: Aging: Epigenetic modifications
- Abstract
- 1: Introduction
- 2: Key hallmarks of aging
- 3: Epigenetics, aging and aging-related diseases
- 4: Anti-aging strategies to improve the health span
- 5: Conclusions
- References
- Chapter Nine: Epigenetics in fetal alcohol spectrum disorder
- Abstract
- 1: Introduction
- 2: DNA methylation changes in FASD
- 3: Histone proteins post-translational modification (PTM) in FASD
- 4: Regulation of microRNAs in FASD
- 5: Conclusions
- References
- Chapter Ten: Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer
- Abstract
- 1: Introduction
- 2: An overview of epigenetic modifications
- 3: Pluripotency factors involved in benign prostatic hyperplasia and prostate cancer
- 4: Crosstalk of epigenetic machinery with signaling in prostate cancer
- 5: CRISPR enables detecting reprogramming to pluripotency
- 6: Conclusion
- References
- Chapter Eleven: Mechanistic aspects of reversible methylation modifications of arginine and lysine of nuclear histones and their roles in human colon cancer
- Abstract
- 1: Introduction
- 2: General insights into histone arginine and lysine methylation and demethylation
- 3: Mechanisms of histone arginine and lysine methylation and demethylation
- 4: Connecting reversible histone arginine and lysine methylations to cellular events
- 5: Histone arginine and lysine methylation-based epigenetic plasticity and transcriptional regulation
- 6: Interplay of arginine and lysine methylation with other histone marks at chromatin territory
- 7: Impact of reversible arginine and lysine methylation of nuclear histones in colon cancer
- 8: Conclusions and future prospects
- References
- Index
- No. of pages: 324
- Language: English
- Edition: 1
- Volume: 197
- Published: April 3, 2023
- Imprint: Academic Press
- Hardback ISBN: 9780443186691
- eBook ISBN: 9780443186707
VS
Vijai Singh
Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.
IM